169 related articles for article (PubMed ID: 28399008)
1. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
Gilbert CR; Gorden JA
Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
[TBL] [Abstract][Full Text] [Related]
2. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.
McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR
Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural agents for pleural infection: fibrinolytics and beyond.
Rahman NM
Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
[No Abstract] [Full Text] [Related]
6. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection.
Goh KJ; Chew WM; Ong JCL; Leong CK; Mohamed Noor IB; Anantham D; Hui LYS; Choong MCM; Liew CJY; Gutierrez MT; Wong JJY; Phua IGCS; Lim WT; Tan QL
Pulm Med; 2023; 2023():6340851. PubMed ID: 38146504
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial.
Wilshire CL; Jackson AS; Vallières E; Bograd AJ; Louie BE; Aye RW; Farivar AS; White PT; Gilbert CR; Gorden JA
JAMA Netw Open; 2023 Apr; 6(4):e237799. PubMed ID: 37043201
[TBL] [Abstract][Full Text] [Related]
11. Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion.
Abdul Hamid MF; Hasbullah AHH; Mohamad Jailaini MF; Nik Abeed NN; Ng BH; Haron H; Md Ali NA; Ismail MI; Nik Ismail NA; Abdul Rahman MR; Ban AY
BMC Pulm Med; 2022 Nov; 22(1):439. PubMed ID: 36419155
[TBL] [Abstract][Full Text] [Related]
12. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
Smith D; Shaw H; Ryder T
Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
[TBL] [Abstract][Full Text] [Related]
14. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
[TBL] [Abstract][Full Text] [Related]
15. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.
Florova G; Azghani A; Karandashova S; Schaefer C; Koenig K; Stewart-Evans K; Declerck PJ; Idell S; Komissarov AA
Am J Respir Cell Mol Biol; 2015 Apr; 52(4):429-37. PubMed ID: 25140386
[TBL] [Abstract][Full Text] [Related]
16. The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Bradley WM; Schaefer C; Koenig K; Idell S
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L562-72. PubMed ID: 26163512
[TBL] [Abstract][Full Text] [Related]
17. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
Rahman NM; Maskell NA; West A; Teoh R; Arnold A; Mackinlay C; Peckham D; Davies CW; Ali N; Kinnear W; Bentley A; Kahan BC; Wrightson JM; Davies HE; Hooper CE; Lee YC; Hedley EL; Crosthwaite N; Choo L; Helm EJ; Gleeson FV; Nunn AJ; Davies RJ
N Engl J Med; 2011 Aug; 365(6):518-26. PubMed ID: 21830966
[TBL] [Abstract][Full Text] [Related]
19. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
[TBL] [Abstract][Full Text] [Related]
20. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
